Multi-society survey: COVID-19 vaccination practices for liver transplant recipients

Calling transplant centres worldwide to share their experiences of COVID-19 vaccination practices

After a first successful survey on the effect of COVID-19 on liver transplant centers, the International Liver Transplantation Society (ILTS), the European Association for the Study of the Liver (EASL), the European Society for Organ Transplantation (ESOT), and the European Liver and Intestine Transplantation Association (ELITA) are leading a collaborative effort to assess the COVID-19 vaccination practices for liver transplant recipients around the globe.


With this multi-society collaboration, we are pleased to be launching a survey on vaccination to explore policy, safety, and efficacy.


Transplant centres may elect to respond to this survey anonymously, indicating only their geographical location. You may skip the specific questions if the data are not available.  If you wish to be acknowledged as a participant and be updated on the publication status, please leave your personal information at the end of the survey.


Once the data is collected and analysed, the results of this survey will be disseminated, via a peer-reviewed publication. We encourage the transplant community to share the call for participation with sister societies around the world.


Your participation is greatly appreciated!

Take the survey: